Literature DB >> 21715690

Voltage-gated sodium channel Nav1.7 maintains the membrane potential and regulates the activation and chemokine-induced migration of a monocyte-derived dendritic cell subset.

Katalin Kis-Toth1, Peter Hajdu, Ildiko Bacskai, Orsolya Szilagyi, Ferenc Papp, Attila Szanto, Edit Posta, Peter Gogolak, Gyorgy Panyi, Eva Rajnavolgyi.   

Abstract

Expression of CD1a protein defines a human dendritic cell (DC) subset with unique functional activities. We aimed to study the expression of the Nav1.7 sodium channel and the functional consequences of its activity in CD1a(-) and CD1a(+) DC. Single-cell electrophysiology (patch-clamp) and quantitative PCR experiments performed on sorted CD1a(-) and CD1a(+) immature DC (IDC) showed that the frequency of cells expressing Na(+) current, current density, and the relative expression of the SCN9A gene encoding Nav1.7 were significantly higher in CD1a(+) cells than in their CD1a(-) counterparts. The activity of Nav1.7 results in a depolarized resting membrane potential (-8.7 ± 1.5 mV) in CD1a(+) IDC as compared with CD1a(-) cells lacking Nav1.7 (-47 ± 6.2 mV). Stimulation of DC by inflammatory signals or by increased intracellular Ca(2+) levels resulted in reduced Nav1.7 expression. Silencing of the SCN9A gene shifted the membrane potential to a hyperpolarizing direction in CD1a(+) IDC, resulting in decreased cell migration, whereas pharmacological inhibition of Nav1.7 by tetrodotoxin sensitized the cells for activation signals. Fine-tuning of IDC functions by a voltage-gated sodium channel emerges as a new regulatory mechanism modulating the migration and cytokine responses of these DC subsets.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21715690     DOI: 10.4049/jimmunol.1003345

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

1.  Targeting ion channels for the treatment of autoimmune neuroinflammation.

Authors:  Stefan Bittner; Sven G Meuth
Journal:  Ther Adv Neurol Disord       Date:  2013-09       Impact factor: 6.570

Review 2.  Sodium channels in astroglia and microglia.

Authors:  Laura W Pappalardo; Joel A Black; Stephen G Waxman
Journal:  Glia       Date:  2016-02-26       Impact factor: 7.452

3.  Modulation of cell function by electric field: a high-resolution analysis.

Authors:  T Taghian; D A Narmoneva; A B Kogan
Journal:  J R Soc Interface       Date:  2015-06-06       Impact factor: 4.118

4.  Pro-inflammatory effects of palytoxin: an in vitro study on human keratinocytes and inflammatory cells.

Authors:  Marco Pelin; Chiara Florio; Cristina Ponti; Marianna Lucafò; Davide Gibellini; Aurelia Tubaro; Silvio Sosa
Journal:  Toxicol Res (Camb)       Date:  2016-05-17       Impact factor: 3.524

Review 5.  The Na(V)1.7 sodium channel: from molecule to man.

Authors:  Sulayman D Dib-Hajj; Yang Yang; Joel A Black; Stephen G Waxman
Journal:  Nat Rev Neurosci       Date:  2012-12-12       Impact factor: 34.870

6.  Voltage-gated sodium channel Nav 1.5 contributes to astrogliosis in an in vitro model of glial injury via reverse Na+ /Ca2+ exchange.

Authors:  Laura W Pappalardo; Omar A Samad; Joel A Black; Stephen G Waxman
Journal:  Glia       Date:  2014-04-17       Impact factor: 7.452

Review 7.  Ion channels and anti-cancer immunity.

Authors:  Gyorgy Panyi; Christine Beeton; Antonio Felipe
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-02-03       Impact factor: 6.237

8.  Bioelectric modulation of macrophage polarization.

Authors:  Chunmei Li; Michael Levin; David L Kaplan
Journal:  Sci Rep       Date:  2016-02-12       Impact factor: 4.379

Review 9.  Microglia in Alzheimer's Disease: A Role for Ion Channels.

Authors:  Laura Thei; Jennifer Imm; Eleni Kaisis; Mark L Dallas; Talitha L Kerrigan
Journal:  Front Neurosci       Date:  2018-09-28       Impact factor: 4.677

Review 10.  Voltage-gated sodium channels and cancer: is excitability their primary role?

Authors:  Sébastien Roger; Ludovic Gillet; Jean-Yves Le Guennec; Pierre Besson
Journal:  Front Pharmacol       Date:  2015-07-29       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.